Bio-gate AG (BIG1) — Working Capital to Net Assets Ratio
Bio-gate AG (BIG1) has a Working Capital to Net Assets ratio of 66.9% as of December 2024. Working capital of €1.20 Million (current assets of €2.25 Million minus current liabilities of €1.06 Million) is measured against net assets of €1.79 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BIG1 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bio-gate AG Working Capital to Net Assets (2020–2024)
This chart shows how Bio-gate AG's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of December 2024, the ratio stands at 66.9%, reflecting working capital of €1.20 Million against net assets of €1.79 Million EUR. See BIG1 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Bio-gate AG (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bio-gate AG from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BIG1 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 66.9% | €1.20 Million | €1.79 Million | €2.25 Million | €1.06 Million | ▼ -2.6 pp |
| 2023 | 69.5% | €2.40 Million | €3.45 Million | €3.37 Million | €967.87K | ▼ -1.5 pp |
| 2022 | 71.0% | €3.02 Million | €4.25 Million | €4.21 Million | €1.19 Million | ▼ -2.3 pp |
| 2021 | 73.4% | €2.77 Million | €3.77 Million | €3.60 Million | €832.26K | ▲ +13.9 pp |
| 2020 | 59.5% | €922.21K | €1.55 Million | €2.04 Million | €1.12 Million | — |